Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-27Clinical Trial Update: Pregnancy and Medically Assisted Conception in Rare Diseases
Clinical trial NCT02450396 on pregnancy and medically assisted conception in rare autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating CLBR001 and SWI019 in autoimmune diseases has been withdrawn from further development.
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-01-09Clinical Trial Update: A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) [Phase 3]
The REMESLE-2 Phase 3 trial of telitacicept for moderately to severely active systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-19Clinical Trial Update: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) [Phase 1]
This Phase 1 trial investigating a CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy for systemic lupus erythematosus has been withdrawn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Lupus
A pilot clinical trial sponsored by ProgenaBiome investigating the role of gut flora in lupus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-24Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 study evaluating the safety and preliminary efficacy of ATA3219 in systemic lupus erythematosus and lupus nephritis has been withd…
-
CLINICAL_TRIALS withdrawal · 2025-03-13Clinical Trial Update: A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus [Phase 1]
A Phase 1 clinical trial evaluating the safety of gusacitinib in patients with systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-10Clinical Trial Update: A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
Lyell Immunopharma's IMPT-514 trial in active refractory lupus nephritis and systemic lupus erythematosus has been withdrawn (Phase 1/Phase …
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial of ustekinumab in Chinese participants with active systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-27Clinical Trial Update: Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases [Phase 1]
A Phase 1 pharmacokinetics study of the investigational antibody Ianalumab in Chinese participants with autoimmune diseases has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Phase 1b/2a in SLE With Budoputug [Phase 1, Phase 2]
A Phase 1b/2a clinical trial of Budoputug for systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-13Clinical Trial Update: Autologous Stem Cell Transplantation: International Lupus Trial [Phase 2, Phase 3]
A clinical trial investigating autologous stem cell transplantation for refractory systemic lupus erythematosus was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-09-13Clinical Trial Update: Acthar SLE (Systemic Lupus Erythematosus) [Phase 4]
Phase 4 clinical trial for Repository Corticotropin Injection in systemic lupus erythematosus was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-11Clinical Trial Update: ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis [Phase 4]
The Phase 4 trial of ACTHAR Gel for membranous lupus nephritis (class V) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-27Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating the safety, pharmacokinetics, and pharmacodynamics of the investigational compound JNJ-56022473 in syste…
-
CLINICAL_TRIALS withdrawal · 2017-05-24Clinical Trial Update: Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease
The clinical trial investigating molecular mechanisms in systemic lupus erythematosus was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-13Clinical Trial Update: Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus [Phase 1]
The Phase 1 trial evaluating allogeneic stem cell transplantation for systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-03Clinical Trial Update: Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients [Phase 1]
A Phase 1 pharmacodynamics study comparing a single subcutaneous dose of SAR113244 to placebo in patients with systemic lupus erythematosus …
-
CLINICAL_TRIALS withdrawal · 2016-01-15Clinical Trial Update: Cardiology Prevention in Systemic Lupus Erythematosus (SLE) [NA]
The University of Pittsburgh-sponsored clinical trial on cardiology prevention in systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-18Clinical Trial Update: The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients [Phase 4]
Phase 4 trial evaluating milnacipran for fatigue and quality of life in lupus patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-10Clinical Trial Update: Levothyroxine in Pregnant SLE Patients [Phase 4]
A Phase 4 clinical trial evaluating levothyroxine in pregnant patients with systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: Study of LJP 394 (Abetimus Sodium) in Lupus Patients [Phase 2]
A Phase 2 study of LJP 394 (Abetimus Sodium) in patients with systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis [Phase 3]
The CHABLIS-SC2 Phase 3 trial of subcutaneous blisibimod for systemic lupus erythematosus (with or without nephritis) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria [Phase 4]
A Phase 4 clinical trial evaluating calcitriol for systemic lupus erythematosus–associated lupus nephritis with persistent proteinuria has b…